# Biolab plans R$ 450 million plant in Pouso Alegre, Brazil

Biolab is planning to open a new plant in Pouso Alegre (MG) with an investment of R$ 450 million. The plant is part of the company's expansion into generics and CNS.

- Type: New facility
- Announced: 2018-07-04
- Where: Pouso Alegre, Minas Gerais, Brazil
- Value: $117.0M (450.0M BRL)
- Status: announced
- Products: generic drugs

## Companies

- [Biolab](https://endata.com/companies/32939.md)

## Sources

- [biolabeco.com.br](https://www.biolabeco.com.br/en/press/biolab-enters-generics-and-evaluates-purchase-in-canada/), 2018-07-04: "Biolab has just entered a new market, generic drugs, with a turnover forecast of more than R$ 150 million in 2019."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.